ArticleFrontiers in public health2025
Effectiveness of self-guided virtual reality exposure therapy for social anxiety disorder: a systematic review and meta-analysis protocol.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Social Anxiety Disorder (SAD) is a prevalent anxiety disorder within contemporary mental health practice, attracting increasing attention. Self-guided virtual reality exposure therapy (SGVRET) has been demonstrated to be an effective intervention for SAD in multiple studies. Although research suggests SGVRET may alleviate SAD symptoms, systematic reviews examining its efficacy in treating SAD remain lacking. Method: This protocol outlines a systematic review designed to assess the efficacy of SGVRET as a intervention for SAD. The study adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Included studies must be randomised controlled trials employing SGVRET as the intervention. A comprehensive search will be conducted across databases including PubMed, Embase, the Cochrane Library, Web of Science, and Scopus, covering studies from the inception of each database up to September 2025. Data synthesis will be performed via meta-analysis or narrative synthesis based on study homogeneity. Furthermore, Stata version 18.0 software will be employed for meta-analysis. Conclusion: This review will systematically evaluate the efficacy of SGVRET in social anxiety disorder, providing an evidence base for its standardised application and assessment among individuals with SAD. Findings from relevant studies will also offer actionable guidance for the design, implementation, and optimisation of digital interventions targeting those with social anxiety. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251151820, identifier CRD420251151820.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.